AHN, Kyu Jeung

Position : Professor / Director Department of Endocrinology and Metabolism

Specialty :

  • Diabetes Mellitus
  • Thyroid disease
  • Pituitary, adrenal and other endocrine disorders

Education :

  • Kyung Hee University(M.D.)
  • Kyung Hee University(Master)
  • Kyung Hee University(Ph.D.)
  • Kyung Hee University Hospital(Residency in Internal Medicine)
  • Samsung Seoul Hospital(Fellowship of Endocrinology and Metabolism)

Experience :

  • Assistant Professor of Internal Medicine, Kwandong University, College of Medicine
  • Associate Professor of Internal Medicine, Eulji University Hospital
  • Visiting research fellow Islet transplantation Program University of Alberta, Canada
  • Professor, Kyung Hee University Hospital at Gang Dong, Seoul, Korea
  • Director of Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gang Dong, Seoul, Korea

Research papers/ Book chapters:

  • Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise (DIABETES OBESITY METABOLISM. 2017;19(12):1681-1687)
  • Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort (JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2017;31(2):375-380)
  • Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial (Diabetes and Metabolism Journal. 2017;41(2):135-145)
  • Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study) (DIABETES OBESITY METABOLISM. 2017;19(5):635-643)
  • Differential Association Between Sarcopenia and Metabolic Phenotype in Korean Young and Older Adults with and without Obesity (OBESITY. 2017;25(1):244-251)
  • The pharmacological stimulation of Nurr1 improves cognitive functions via enhancement of adult hippocampal neurogenesis (STEM CELL RESEARCH. 2016;17(3):534-543)
  • Aster spathulifolius Maxim extract reduces body weight and fat mass in obese humans (NUTRITION RESEARCH. 2016;36(7):671-678)
  • Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial (JOURNAL OF DIABETES. 2016;8(3):405-413)
  • Hypoglycemia and medical expenses in patients with type 2 diabetes mellitus: An analysis based on the korea national diabetes program cohort (PLoS ONE. 2016;11(2):1-10)
  • A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise (DIABETES-METABOLISM RESEARCH AND REVIEWS. 2015;31(3):295-306)
  • The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea (Diabetes and Metabolism Journal. 2015;39(3):177-187)
  • Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial (LANCET DIABETES & ENDOCRINOLOGY. 2015;3(4):254-262)
  • etc.